ImmunoGen (IMGN) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

ImmunoGen (IMGN) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 3, 2023 (08:16)

Sector: Healthcare

The share price of ImmunoGen, Inc. (IMGN) now

What analysts predict: $23
52-week High/Low: $20.69 / $3.605

50/200 Day Moving Average: $15.08 / $12.55

This figure corresponds to the Average Price over the previous 50/200 days. For ImmunoGen stocks, the 50-day moving average is the support level today.

For ImmunoGen stocks, the 200-day moving average is the support level today.

Are you interested in ImmunoGen, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the ImmunoGen stock price in 2023, 2024, 2025, 2026, 2027. How much will one ImmunoGen share be worth in 2023 - 2027?

When should I take profit in ImmunoGen stock? When should I record a loss on ImmunoGen stock? What are analysts' forecasts for ImmunoGen stock? What is the future of ImmunoGen stock? We forecast ImmunoGen stock performance using neural networks based on historical data on ImmunoGen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

ImmunoGen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for ImmunoGen shares. This happens once a day.




Historical and forecast chart of ImmunoGen stock

The chart below shows the historical price of ImmunoGen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ImmunoGen stock price can be found in the table below.

Long-term forecasts by years.

ImmunoGen, Inc., a clinical-stage biotechnology company, is developing antibody-drug conjugate (ADC) therapies for cancer. Its candidate products include mirvetuximab soravtansine, an alpha-folate receptor-targeted ADC that is in phase III clinical trials for the treatment of platinum-resistant ovarian cancer; and IMGN632, an ADC targeting CD123, which is in phase I clinical trials for the treatment of AML and blast plasmacytoid dendritic cell neoplasms.

ImmunoGen daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 05 29.88 29.70 30.29 1.99
Dec 06 29.76 29.55 30.30 2.52
Dec 07 29.13 28.63 29.48 2.97
Dec 08 28.97 28.60 29.49 3.12
Dec 09 29.48 29.00 29.61 2.13
Dec 10 30.03 29.50 30.32 2.81
Dec 11 30.16 29.72 30.37 2.17
Dec 12 29.82 29.44 30.22 2.66
Dec 13 29.22 28.91 29.55 2.23
Dec 14 28.85 28.56 29.33 2.69
Dec 15 28.37 28.17 28.61 1.58
Dec 16 28.05 27.53 28.25 2.62
Dec 17 28.45 28.17 28.77 2.14
Dec 18 28.25 27.93 28.71 2.79
Dec 19 28.54 28.33 28.77 1.55
Dec 20 28.60 28.20 28.82 2.22
Dec 21 28.37 27.97 28.84 3.10
Dec 22 28.32 28.00 28.80 2.86
Dec 23 28.50 28.02 28.98 3.39
Dec 24 28.57 28.08 29.06 3.49
Dec 25 28.58 28.17 28.75 2.03
Dec 26 28.79 28.53 29.14 2.14
Dec 27 28.87 28.45 29.27 2.89
Dec 28 28.63 28.11 28.91 2.83
Dec 29 28.72 28.20 29.19 3.54
Dec 30 29.06 28.71 29.20 1.70
Dec 31 28.83 28.40 29.11 2.50
Jan 01 28.37 27.87 28.70 2.95
Jan 02 28.37 28.01 28.83 2.91
Jan 03 28.50 28.30 28.89 2.11

ImmunoGen Daily Price Targets


ImmunoGen Stock Forecast 12-05-2023.

Forecast target price for 12-05-2023: $29.88.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 1.951%.
Pessimistic target level: 29.70
Optimistic target level: 30.29

ImmunoGen Stock Forecast 12-06-2023.

Forecast target price for 12-06-2023: $29.76.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 2.462%.
Pessimistic target level: 29.55
Optimistic target level: 30.30

ImmunoGen Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $29.13.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 2.887%.
Pessimistic target level: 28.63
Optimistic target level: 29.48

ImmunoGen Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $28.97.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 3.027%.
Pessimistic target level: 28.60
Optimistic target level: 29.49

ImmunoGen Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $29.48.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 2.084%.
Pessimistic target level: 29.00
Optimistic target level: 29.61

ImmunoGen Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $30.03.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 2.733%.
Pessimistic target level: 29.50
Optimistic target level: 30.32

IMGN (IMGN) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Dec. 18.05 17.29 19.11 9.49

ImmunoGen forecast for this year


ImmunoGen Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $18.0507. Pessimistic: $17.29. Optimistic: $19.11



ImmunoGen (IMGN) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 20.16 19.41 21.25 8.68
Feb 19.35 17.66 20.48 13.75
Mar 19.75 18.57 21.92 15.28
Apr 17.80 17.24 19.72 12.59
May 17.77 16.86 19.80 14.81
Jun 17.66 17.08 18.99 10.05
Jul 18.88 17.92 20.95 14.47
Aug 19.22 17.75 21.18 16.20
Sep 16.80 15.24 17.33 12.07
Oct 17.15 15.79 19.21 17.81
Nov 15.66 15.14 17.54 13.66
Dec 17.89 16.58 19.77 16.15

ImmunoGen (IMGN) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 20.44 18.79 21.94 14.39
Feb 19.92 18.25 20.97 12.97
Mar 19.74 18.62 20.60 9.63
Apr 22.26 20.62 23.86 13.57
May 21.92 20.71 23.21 10.77
Jun 24.52 22.39 26.47 15.42
Jul 22.87 20.19 24.75 18.43
Aug 21.74 19.52 22.88 14.68
Sep 21.38 19.61 23.30 15.83
Oct 21.63 20.69 23.65 12.49
Nov 22.41 20.53 24.87 17.44
Dec 25.37 22.82 27.96 18.38

ImmunoGen (IMGN) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 26.82 24.85 29.27 15.12
Feb 25.77 23.92 27.36 12.58
Mar 23.03 21.89 24.06 9.04
Apr 22.16 20.83 23.69 12.07
May 20.40 19.42 22.76 14.66
Jun 21.66 19.41 22.73 14.58
Jul 21.53 19.88 23.85 16.65
Aug 22.59 20.46 24.96 18.05
Sep 25.10 22.24 25.93 14.23
Oct 27.43 24.55 28.46 13.73
Nov 28.38 26.00 31.06 16.31
Dec 31.78 30.50 34.98 12.81

ImmunoGen (IMGN) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 36.27 32.51 39.86 18.43
Feb 40.73 38.65 43.90 11.97
Mar 37.43 33.33 40.01 16.70
Apr 34.68 30.52 38.79 21.32
May 35.56 34.23 38.60 11.33
Jun 37.80 35.53 42.05 15.51
Jul 35.99 33.13 37.82 12.42
Aug 36.42 32.70 37.68 13.19
Sep 36.15 32.35 39.24 17.55
Oct 33.81 31.38 35.74 12.20
Nov 34.42 33.24 36.08 7.87
Dec 33.75 32.64 35.12 7.06

ImmunoGen information and performance

ImmunoGen Address

830 WINTER ST, WALTHAM, MA, US

Market Capitalization: 4 276 200 000 $

Market capitalization of the ImmunoGen, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of IMGN shares in the company outstanding by the market price of one share.

EBITDA: -78 459 000 $

EBITDA of ImmunoGen is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0113

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.28

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 4.078
Quarterly Revenue Growth YOY: 6.38
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 8.87

Enterprise Value (EV) /Revenue

EV To EBITDA: -4.372

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 266264000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.